Skip to search formSkip to main contentSkip to account menu

CD19 Ag:PrThr:Pt:Tiss:Ord:Immune stain

Known as: CD19 , Ag:Présence-Seuil:Temps ponctuel:Tissu:Ordinal:Coloration immunologique, CD19 ??:PrThr:??????:??:???:????????????????????? ???????, CD19 ??:????:????:??:????:???? 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Für Patienten mit therapieresistenten B-Zell-Malignomen ist eine allogene Stammzelltransplantation die einzige kurative Option… 
2014
2014
L'invention concerne des compositions et des methodes de traitement de maladies associees a l'expression de CD19. L'invention… 
2010
2010
Verleichende Genexpressionsanalysen der padiatrischen Akuten Lymphoblastischen Leukamie (cALL) mit nicht-malignen Gewebe… 
2009
2009
Objective. To analyze the relationship between clinical benefits and immunological changes in patients with systemic sclerosis… 
2008
2008
A Spanish study that investigated the prog­ nostic value of immunophenotyping in patients with multiple myeloma has found that… 
2008
2008
A Spanish study that investigated the prog­ nostic value of immunophenotyping in patients with multiple myeloma has found that… 
2008
2008
A Spanish study that investigated the prog­ nostic value of immunophenotyping in patients with multiple myeloma has found that… 
2006
2006
The ability to selectively target liposomal anticancer drugs via specific ligands against antigens expressed on malignant cells…